Interestingly, OCSs have been shown to increase appetite, body weight, and circulating levels of leptin and adiponectin in patients with asthma and chronic obstructive pulmonary disease (COPD) [10,11]. This evidence concerns the gene ADIPOQ and chronic obstructive pulmonary disease.